• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
You are here:   Home > EZSourcing > Sourcing Request > Semaglutide

Semaglutide
Categories: API Equipment>Chemical and Biochemical Reactors
Expected Quantity: 100 Gram(s)
Valid To: 2027-06-03
Delivery To: China Mainland
Date Posted: 2025-03-04
The sourcing request is closed now.
Request Details
Semaglutide, sold under the brand names Ozempic, Wegovy, and Rybelsus, is an antidiabetic drug for type 2 diabetes and a weight loss drug for long-term weight management developed by Novo Nordisk in 2012. It is a peptide similar to glucagon-like peptide-1 with a modified side chain. It can be injected subcutaneously or orally. NovoTex is used to treat type 2 diabetes, while NovoWin is used for weight loss.
Buyer's Business Info
Only registered supplier members are allowed to view Buyers contact details
Please
Quote
Recommended Sourcing Requests
Preparation Equipment
Quantity：0
Date Posted：2010-10-21
More >
API Equipment
Quantity：0
Date Posted：2012-08-07
More >
Cell culture plates
Quantity：100
Date Posted：2014-05-20
More >
Tiaprofenic acid
Quantity：300 Kilogram(s)
Date Posted：2024-05-04
More >
Related News
XiaonishaAugust 12, 2024
XiaomichongJuly 19, 2024
XiaomichongJuly 05, 2024
XiaomichongJuly 17, 2024

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service